Karyopharm grants 1,850 inducement RSUs to two new hires

• Karyopharm Therapeutics granted 1,850 restricted stock units to two newly hired employees under its 2022 Inducement Stock Incentive Plan.
• Awards were granted on Aug. 31, 2026.
• RSUs vest over three years, with one-third vesting on each anniversary of the grant date.
• Vesting requires continued service through each vesting date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609011605PR_NEWS_USPR_____NE35655) on September 01, 2026, and is solely responsible for the information contained therein.